Kitagawa Koichi

キタガワコウイチ | Kitagawa Koichi

Affiliation and department：
Job title： Assistant Professor

Research field (1)： Tumor biology

Research theme for competitive and other funds (1)：

Papers (36)：

植木秀登, 日向信之, 北川孝一, 岡村泰義, 原琢人, 寺川智章, 古川順也, 原田健一, 中野雄造, 白川利朗, et al. ペムブロリズマブを使用した進行性尿路上皮癌患者の予後予測因子についての免疫組織学的検討. 日本泌尿器科学会総会. 2021. 109回. PP26-02
Kayo Osawa, Katsumi Shigemura, Koichi Kitagawa, K Kuntaman, Ni Made Mertaniasih, Wahyu Setyarini, Dita Arizandy, Dadik Rahadjo, Ro Osawa, Toshiro Shirakawa, et al. Difference of Phenotype and Genotype Between Human and Environmental: Isolated Vibrio cholerae in Surabaya, Indonesia. Indian journal of microbiology. 2020. 60. 2. 230-238
Atsushi Uda, Katsumi Shigemura, Koichi Kitagawa, Kayo Osawa, Kenichiro Onuma, Shigeaki Inoue, Joji Kotani, Yonmin Yan, Yuzo Nakano, Tatsuya Nishioka, et al. How Does Antimicrobial Stewardship Affect Inappropriate Antibiotic Therapy in Urological Patients?. Antibiotics (Basel, Switzerland). 2020. 9. 2
Koichi Kitagawa, Katsumi Shigemura, Masashi Nomi, Nozomi Takami, Naoki Yamada, Masato Fujisawa. Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit. Spinal cord. 2020
Shigemura K, Kitagawa K, Chen KC, Sung SY, Fujisawa M. Effect of Preoperative Dutasteride on Holmium Laser Enucleation of the Prostate. Urologia internationalis. 2019. 1-5

ｍore...

MISC (1)：

Books (1)：

Lectures and oral presentations (24)：

Oral cancer vaccine using recombinant Bifidobacterium expressing WT1 protein and anti-PD1 antibody induced WT1 specific immune responses via gut immune system in murine bladder cancer model
(CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE 2019)
Combination cancer immunotherapy of anti-PD-1 antibody with recombinant adenovirus vector carrying p53 gene for urogenital cancers
(CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE 2019)
Overexpression of SOCS3 mediated by adenovirus vector inhibited cell proliferation and increased chemosensitivity in triple-negative breast cancer cells in vitro and in vivo.
(The 25th Annual Meeting of Japan Society of Gene and Cell Therapy 2019)
WT1 oral cancer vaccine combined with anti-PD-1 antibody completely suppressed tumor growth in a murine bladder cancer model
(CIMT 2019 Annual Meeting 2019)
Possible molecular targeted therapy for invasive bladder cancer: Sonic hedgehog signaling inhibitor, cyclopamine
(34th Annual EAU Congress 2019)

ｍore...

Education (1)：

Professional career (2)：

Awards (1)：

2017/06 - 日本ビフィズス菌センター/腸内細菌学会第21回腸内細菌学会最優秀発表賞 Anti-tumor immune responses induced by oral cancer vaccine using recombinant Bifidobacterium displaying Wilms’ tumor 1 protein

Association Membership(s) (4)：

THE MOLECULAR BIOLOGY SOCIETY OF JAPAN , THE JAPANESE SOCIETY FOR VACCINOLOGY , American Society of Gene & Cell Therapy , 日本遺伝子細胞治療学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page